Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer.
Kaburagi T, Satoh H, Hayashihara K, Endo T, Hizawa N, Kurishima K, Nishimura Y, Hashimoto T, Nakamura H, Kishi K, Inagaki M, Nawa T, Ichimura H, Ishikawa H, Kagohashi K, Fukuoka T, Shinohara Y, Kamiyama K, Sato Y, Sakai M, Matsumura T, Uchiumi K, Furukawa K.
Kaburagi T, et al.
Oncol Lett. 2013 Feb;5(2):435-439. doi: 10.3892/ol.2012.1048. Epub 2012 Nov 27.
Oncol Lett. 2013.
PMID: 23420613
Free PMC article.